Evidence map›Paper›PMID 34552584›Full record

ArticleFrontiers in immunology2021

Dorothee Kretschmer, Ricarda Breitmeyer, Cordula Gekeler, Marco Lebtig, Katja Schlatterer, Mulugeta Nega, Mark Stahl, Daphne Stapels, Suzan Rooijakkers, Andreas Peschel

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Methicillin-resistantiScience · 2026
    Review
  2. α-hemolysin polymorphisms in methicillin-resistantbioRxiv : the preprint server for biology · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Type 2 immunity in allergic diseases.Cellular & molecular immunology · 2025
    Review
  9. Pathogens (Basel, Switzerland) · 2025
    Review
  10. Matrix porosity is associated withbioRxiv : the preprint server for biology · 2024
    Article
  11. Frontiers in immunology · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Frontiers in cellular and infection microbiology · 2023
    Review
  17. The Upregulation ofAnimals : an open access journal from MDPI · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Dorothee KretschmerInterfaculty Institute for Microbiology and Infection Medicine Tübingen (IMIT), Infection Biology, University of Tübingen, Tübingen, Germany.
Ricarda BreitmeyerInterfaculty Institute for Microbiology and Infection Medicine Tübingen (IMIT), Infection Biology, University of Tübingen, Tübingen, Germany.
Cordula GekelerInterfaculty Institute for Microbiology and Infection Medicine Tübingen (IMIT), Infection Biology, University of Tübingen, Tübingen, Germany.
Marco LebtigInterfaculty Institute for Microbiology and Infection Medicine Tübingen (IMIT), Infection Biology, University of Tübingen, Tübingen, Germany.
Katja SchlattererInterfaculty Institute for Microbiology and Infection Medicine Tübingen (IMIT), Infection Biology, University of Tübingen, Tübingen, Germany.
Mulugeta NegaCluster of Excellence EXC2124 "Controlling Microbes to Fight Infections", Tübingen, Germany.
Mark StahlCenter for Plant Molecular Biology (ZMBP), University of Tübingen, Tübingen, Germany.
Daphne StapelsDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Suzan RooijakkersDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Andreas PeschelInterfaculty Institute for Microbiology and Infection Medicine Tübingen (IMIT), Infection Biology, University of Tübingen, Tübingen, Germany.
University of Tübingen · DEGerman Center for Infection Research · DEUniversity Medical Center Utrecht · NLUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophil granulocytes act as a first line of defense against pathogenic staphylococci. However,

Indexed as

AnimalsBacterial ProteinsBacterial ToxinsCells, CulturedHumansImmune EvasionMiceMice, Inbred C57BLNeutrophilsSerine ProteasesStaphylococcal InfectionsStaphylococcus aureusBacterial ProteinsBacterial ToxinsSerine Proteasesstaphylococcal delta toxinformyl-peptide receptor 2neutrophil serine protease inhibitorsneutrophil serine proteasesphenol-soluble modulinsStaphylococciStaphylococcus aureus

Identifiers

PMID34552584
PMCPMC8451722
OpenAlexW3197568736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.